Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome.
Buchwald
B
B
Department of Neurology, University of Würzburg, Germany.
Dudel
J
J
Toyka
K V
KV
D000200:Action Potentials; D000818:Animals; D001323:Autoantibodies / Q000097:blood / Q000494:pharmacology*; D003964:Diaphragm; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000494:pharmacology*; D066298:In Vitro Techniques; D051379:Mice; D008807:Mice, Inbred BALB C; D019846:Miller Fisher Syndrome / Q000097:blood / Q000276:immunology* / Q000628:therapy; D009045:Motor Endplate / Q000502:physiology*; D009469:Neuromuscular Junction / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D018408:Patch-Clamp Techniques; D010956:Plasmapheresis
D001323:Autoantibodies; D005732:Gangliosides; D007074:Immunoglobulin G; C039129:GQ1b ganglioside